Global Below-the-knee Balloon Dilatation Catheter Market Strategic Research Report
By Type: With Sheath 5F, With Sheath 4F
By Application: Hospital, Clinic
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Boston Scientific, Medtronic, Cook Medical, Terumo Interventional Systems, BD (Becton Dickinson), Biotronik, Abbott Laboratories, Cordis, B. Braun Melsungen, AngioDynamics, Surmodics, iVascular, Zylox-Tonbridge, MicroPort Endovascular, Lepu Medical, Acotec Scientific, OrbusNeich, Nipro
Overview
Scope of the Report
The global Below-the-knee Balloon Dilatation Catheter market size is predicted to grow from US$ 2,739 million in 2025 to US$ 4,306 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.
Below-the-knee Balloon Dilatation Catheter refers to a percutaneous transluminal angioplasty catheter designed to dilate narrowed or occluded arteries below the knee, especially small and distal infrapopliteal vessels. The catheter is inserted over a guidewire and advanced through the vascular system to the lesion, where the balloon is inflated to restore vessel lumen and improve blood flow to the lower leg and foot. These catheters are typically designed with low crossing profile, long shaft length, small balloon diameter, long balloon length, hydrophilic coating, high pushability, high trackability and compatibility with 0.014" or 0.018" guidewires. In this report, the market mainly includes standard BTK PTA balloons, low-profile 0.014" BTK balloons, 0.018" infrapopliteal balloons, long BTK balloons, high-pressure BTK balloons, pedal-access balloons and peripheral balloons specifically marketed for below-the-knee or infrapopliteal procedures. The 2025 benchmark ASP is US$620 / unit, sales volume is 4,516.13k units, and average gross margin is 60%. The upstream industry chain includes balloon polymers, catheter shaft materials, guidewire-compatible tubing, hydrophilic coatings, radiopaque marker bands, adhesives, hypotubes, hubs, inflation ports, sterilization packaging and precision extrusion materials. The midstream includes balloon forming, catheter extrusion, shaft bonding, marker band assembly, coating, balloon folding, crimping, leak testing, burst pressure testing, trackability testing, sterilization, packaging, regulatory approval and quality inspection. The downstream includes interventional radiology departments, vascular surgery departments, cardiology catheterization labs, diabetic foot centers, limb salvage centers, hospitals, ambulatory vascular centers, medical device distributors and group purchasing organizations.
Below-the-knee balloon dilatation catheters are an important device category in limb salvage and peripheral artery disease intervention. Demand is driven by the rising prevalence of diabetes, chronic limb-threatening ischemia, peripheral artery disease, aging populations and greater clinical preference for minimally invasive endovascular therapy before surgical bypass or amputation. BTK lesions are often long, calcified, diffuse and located in small tortuous vessels, so catheter deliverability, crossing profile, pushability, hydrophilic coating, long balloon length and controlled inflation performance are critical. Compared with above-the-knee PTA balloons, BTK balloons require smaller diameters, longer shaft options and better distal vessel navigation. Compared with drug-coated balloons, plain BTK balloon dilatation catheters remain important because infrapopliteal DCB adoption has been more selective and plain PTA is still widely used in many markets. Market growth is supported by more diabetic foot programs, limb salvage centers, outpatient vascular centers, pedal access techniques and new low-profile catheter designs. However, the market faces pressure from reimbursement limits, price-based tenders, product commoditization, restenosis after plain balloon angioplasty, competition from drug-coated balloons, scoring balloons, atherectomy, intravascular lithotripsy and bypass surgery. Future competition will focus on ultra-low crossing profile, longer balloons, improved rewrap, faster deflation, higher rated burst pressure, better torque response, pedal access compatibility, radial-to-peripheral compatibility and integration with vessel preparation workflows.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Below-the-knee Balloon Dilatation Catheter market?
What factors are driving Below-the-knee Balloon Dilatation Catheter market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Below-the-knee Balloon Dilatation Catheter market opportunities vary by end market size?
How does Below-the-knee Balloon Dilatation Catheter break out by Type, by Application?
This report presents a comprehensive overview of the global Below-the-knee Balloon Dilatation Catheter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- With Sheath 5F
- With Sheath 4F
Segment by Balloon Length
- Short Balloon (≤ 40 mm)
- Medium Balloon (40 – 100 mm)
- Long Balloon (> 100 mm)
Segment by Drug Coating Type
- Paclitaxel-Coated Balloons
- Sirolimus-Coated Balloons
- Non-Drug-Coated Balloons
Segment by Application
- Hospital
- Clinic
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Below-the-knee Balloon Dilatation Catheter market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Hospital, Clinic evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Below-the-knee Balloon Dilatation Catheter Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 With Sheath 5F
- 3.1.3 With Sheath 4F
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Hospital
- 4.1.3 Clinic
- 4.1.4 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Boston Scientific
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Medtronic
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Cook Medical
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Terumo Interventional Systems
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 BD (Becton Dickinson)
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Biotronik
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Abbott Laboratories
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Cordis
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 B. Braun Melsungen
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 AngioDynamics
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 Surmodics
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 iVascular
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Zylox-Tonbridge
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 MicroPort Endovascular
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Lepu Medical
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
- 8.16 Acotec Scientific
- 8.16.1 Company Overview
- 8.16.2 Key Products & Segments
- 8.16.3 Financial Performance (2023–2025)
- 8.16.4 Business Strategy
- 8.16.5 SWOT Analysis
- 8.16.6 Strategic Implications (2026–2032)
- 8.17 OrbusNeich
- 8.17.1 Company Overview
- 8.17.2 Key Products & Segments
- 8.17.3 Financial Performance (2023–2025)
- 8.17.4 Business Strategy
- 8.17.5 SWOT Analysis
- 8.17.6 Strategic Implications (2026–2032)
- 8.18 Nipro
- 8.18.1 Company Overview
- 8.18.2 Key Products & Segments
- 8.18.3 Financial Performance (2023–2025)
- 8.18.4 Business Strategy
- 8.18.5 SWOT Analysis
- 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the size of the global Below-the-knee Balloon Dilatation Catheter market?
What is the forecast CAGR for the Below-the-knee Balloon Dilatation Catheter market?
What is Below-the-knee Balloon Dilatation Catheter?
How is the Below-the-knee Balloon Dilatation Catheter market segmented by type?
What are the key applications of Below-the-knee Balloon Dilatation Catheter?
Which companies are profiled in the Below-the-knee Balloon Dilatation Catheter market report?
What geographies does the Below-the-knee Balloon Dilatation Catheter market analysis include?
What are the key demand drivers for Below-the-knee Balloon Dilatation Catheter?
Who should buy the Below-the-knee Balloon Dilatation Catheter market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Below-the-knee Balloon Dilatation Catheter Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices